POWERS PETERSON, M.D.; CELINE M. STAHL-BAYLISS, M.D.
PETERSON P, STAHL-BAYLISS CM. Cytomegalovirus Thrombophlebitis After Successful DHPG Therapy. Ann Intern Med. 1987;106:632-633. doi: 10.7326/0003-4819-106-4-632
Download citation file:
Published: Ann Intern Med. 1987;106(4):632-633.
To the editor: Cytomegalovirus is a frequent cause of opportunistic infections in patients with the acquired immunodeficiency syndrome (AIDS) (1). 9-[1,3-dihydroxy-2-propoxy)methyl]guanine (DHPG) is a new, potent, and broadly active antiherpetic agent structurally similar to acyclovir. It was administered intravenously for 2 weeks to a male homosexual patient with persistent cytomegalovirus viremia. He was free of cytomegalovirus infection for 1 year and then developed a unique, previously unreported complication, cytomegalovirus thrombophlebitis.
A 34-year-old white homosexual man was diagnosed with AIDS in November 1983, when Kaposi sarcoma was histologically confirmed. He remained well until November 1984, when he developed low-grade fevers, diffuse
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only